Fairvalue-Calculator Fairvalue-Calculator
EN DE

HLB bioStep Co (278650) Fair Value & Analysis

Healthcare · KR · Market cap 50.8B KRW

Price2,785 KRW
Fair Value4,021 KRW
Upside+44.4%
Quality91/100
Evidence: Medium Range 3,127 KRW – 5,457 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

HLB bioStep Co (278650) currently trades at 2,785 KRW, while our model-based Fair Value estimate is 4,021 KRW — implying the stock looks roughly 44.4% undervalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug development consulting and clinical trial services, and bioanalysis items. The company was formerly known as KNOTUS Co.,Ltd. HLB bioStep Co.,Ltd. was founded in 2012 and is headquartered in Incheon, South Korea.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is HLB bioStep Co (278650) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 4,021 KRW versus a price of 2,785 KRW — about +44% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 278650?
Our 21-model fair value for HLB bioStep Co is 4,021 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 2,785 KRW.
What is the quality score of 278650?
HLB bioStep Co has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.